These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 12902982

  • 1. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
    Lindström MS, Wiman KG.
    Oncogene; 2003 Aug 07; 22(32):4993-5005. PubMed ID: 12902982
    [Abstract] [Full Text] [Related]

  • 2. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
    Palmero I, Murga M, Zubiaga A, Serrano M.
    Oncogene; 2002 May 02; 21(19):2939-47. PubMed ID: 12082524
    [Abstract] [Full Text] [Related]

  • 3. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
    Santoni-Rugiu E, Duro D, Farkas T, Mathiasen IS, Jäättelä M, Bartek J, Lukas J.
    Oncogene; 2002 Sep 19; 21(42):6498-509. PubMed ID: 12226753
    [Abstract] [Full Text] [Related]

  • 4. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL.
    Oncogene; 2001 Oct 25; 20(48):6983-93. PubMed ID: 11704823
    [Abstract] [Full Text] [Related]

  • 5. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
    Raveh T, Droguett G, Horwitz MS, DePinho RA, Kimchi A.
    Nat Cell Biol; 2001 Jan 25; 3(1):1-7. PubMed ID: 11146619
    [Abstract] [Full Text] [Related]

  • 6. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT, Hong S, Mayhew CN, Rogers PM, Knudsen ES, Johnson DG.
    Mol Cancer Res; 2004 Apr 25; 2(4):203-14. PubMed ID: 15140942
    [Abstract] [Full Text] [Related]

  • 7. E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.
    Elliott MJ, Dong YB, Yang H, McMasters KM.
    Clin Cancer Res; 2001 Nov 25; 7(11):3590-7. PubMed ID: 11705881
    [Abstract] [Full Text] [Related]

  • 8. ATM activity contributes to the tumor-suppressing functions of p14ARF.
    Li Y, Wu D, Chen B, Ingram A, He L, Liu L, Zhu D, Kapoor A, Tang D.
    Oncogene; 2004 Sep 23; 23(44):7355-65. PubMed ID: 15258567
    [Abstract] [Full Text] [Related]

  • 9. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
    Hershko T, Chaussepied M, Oren M, Ginsberg D.
    Cell Death Differ; 2005 Apr 23; 12(4):377-83. PubMed ID: 15706352
    [Abstract] [Full Text] [Related]

  • 10. Myc lacks E2F1's ability to suppress skin carcinogenesis.
    Rounbehler RJ, Schneider-Broussard R, Conti CJ, Johnson DG.
    Oncogene; 2001 Aug 30; 20(38):5341-9. PubMed ID: 11536046
    [Abstract] [Full Text] [Related]

  • 11. E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis.
    Rogoff HA, Pickering MT, Debatis ME, Jones S, Kowalik TF.
    Mol Cell Biol; 2002 Aug 30; 22(15):5308-18. PubMed ID: 12101227
    [Abstract] [Full Text] [Related]

  • 12. ARF differentially modulates apoptosis induced by E2F1 and Myc.
    Russell JL, Powers JT, Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG.
    Mol Cell Biol; 2002 Mar 30; 22(5):1360-8. PubMed ID: 11839803
    [Abstract] [Full Text] [Related]

  • 13. Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation.
    Ayrault O, Andrique L, Fauvin D, Eymin B, Gazzeri S, Séité P.
    Oncogene; 2006 Dec 07; 25(58):7577-86. PubMed ID: 16924243
    [Abstract] [Full Text] [Related]

  • 14. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
    Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG.
    Cancer Res; 2002 Jun 01; 62(11):3276-81. PubMed ID: 12036945
    [Abstract] [Full Text] [Related]

  • 15. ARF and ATM/ATR cooperate in p53-mediated apoptosis upon oncogenic stress.
    Pauklin S, Kristjuhan A, Maimets T, Jaks V.
    Biochem Biophys Res Commun; 2005 Aug 26; 334(2):386-94. PubMed ID: 16004968
    [Abstract] [Full Text] [Related]

  • 16. Involvement of E2F1 transcriptional activity in cadmium-induced cell-cycle arrest at G1 in human lung fibroblasts.
    Choi YJ, Yin HQ, Suh HR, Lee YJ, Park SR, Lee BH.
    Environ Mol Mutagen; 2011 Mar 26; 52(2):145-52. PubMed ID: 20839231
    [Abstract] [Full Text] [Related]

  • 17. A novel mitochondrial protein DIP mediates E2F1-induced apoptosis independently of p53.
    Stanelle J, Tu-Rapp H, Pützer BM.
    Cell Death Differ; 2005 Apr 26; 12(4):347-57. PubMed ID: 15565177
    [Abstract] [Full Text] [Related]

  • 18. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence.
    Peeper DS, Shvarts A, Brummelkamp T, Douma S, Koh EY, Daley GQ, Bernards R.
    Nat Cell Biol; 2002 Feb 26; 4(2):148-53. PubMed ID: 11812999
    [Abstract] [Full Text] [Related]

  • 19. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes.
    Solá S, Castro RE, Kren BT, Steer CJ, Rodrigues CM.
    Biochemistry; 2004 Jul 06; 43(26):8429-38. PubMed ID: 15222754
    [Abstract] [Full Text] [Related]

  • 20. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation.
    Nip J, Strom DK, Eischen CM, Cleveland JL, Zambetti GP, Hiebert SW.
    Oncogene; 2001 Feb 22; 20(8):910-20. PubMed ID: 11314026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.